Search results for: NICE
Filter search results
Tony Culyer
3 February 2023
…Institute for Health and Clinical Excellence (NICE) and he still chairs the International Decision Support Initiative – the successor to NICE International. Until recently he chaired the Office of Health…
Alastair Fischer
30 August 2023
…Institute of Clinical Excellence (NICE) where he remained for 16 years, first in the economic evaluation of drugs and then a longer period in Public Health. His main research interests…
Around The World in HTAs: Türkiye – The bumpy road toward transformation
31 January 2024
…NICE in the UK. This is promising but political will is required to determine the role of HTA in reimbursement decisions. After the establishment of an independent HTA body, an…
Rare Disease Day 2024: Why Do We Care About Rare?
29 February 2024
…in the NICE Evaluation of Multi-Indication Medicines for Rare and Ultra-Rare Diseases – OHE. Office of Health Economics. Published January 9, 2021. Accessed February 27, 2024. https://www.ohe.org/publications/case-study-analysis-challenges-nice-evaluation-multi-indication-medicines-rare-and/ Cole A, Cubi-Molla…
GLP-1 Receptor Agonists: Shifting Obesity Management
12 May 2025
…GLP-1s in the UK? In the UK, as reported within a NICE published news article, GLP-1 receptor agonists are only prescribed when someone has a body mass index (BMI) over…
New research reveals, in carers’ own words, the multidimensional burden of caring for leukemia patients
20 November 2025
…bit overwhelmed. I was like: “This is my mother’s life.” What am I supposed to say? It doesn’t feel nice when you have to make decisions about someone else’s life.”…
Dalia Dawoud
1 June 2026
…worked at leading organisations including NICE, where she was the founding Associate Director of NICE HTA Innovation Laboratory (HTA Lab) with projects including AI in economic modelling and the evaluation…
Incorporating Multiple Criteria in HTA
19 April 2011
…pay for depends, of course, on the health gain that results. Health technology assessment (HTA) and cost-effectiveness analysis have become the core for many such decisions — by NICE in…
Measuring Value with Pharmacoeconomics
26 May 2011
…provinces in Canada. Since then, the UK has established NICE (1999) and several other European countries request economic analyses for at least some new medicines, including Belgium, Finland, Ireland, Norway,…